title: Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge.
abstract: Infectious arthritis due to Candida glabrata is very rare. A 40-year-old Iranian man had developed a painful swelling on the left knee since a year ago. A surgery (meniscectomy) was performed on his knee. However, in follow-up visit after 2 months, the patient's condition was deteriorated. Direct examination of synovial fluid with Gram and hematoxylin-eosin stains were negative for any bacterial or fungal infection or crystal elements; however, inoculation into BACTEC™ Mycosis IC/F and Plus Aerobic/F culture bottles led to the isolation of a yeast strain. The macroscopic examination on CHROMagar™ Candida medium combined with microscopical examination on CMT80 agar made a presumptive identification of the isolate to be considered as C. glabrata, and it was later on confirmed by ITS sequencing. Initial empirical treatment was started with intravenous amphotericin B for 4 weeks followed by oral itraconazole which was unsuccessful. Prescription of an oral 150-mg tablet of fluconazole was considered for a 2-month course. All symptoms completely declined, and no recurrence of infection was detected. Antifungal susceptibility testing (AFST) was performed for this isolate, and the result showed sensitivity to both amphotericin B and itraconazole and less susceptibility to fluconazole while clinical recovery was achieved by fluconazole. In any suspected clinical case caused by infectious agents, application of an effective fungal diagnostic test should be considered to avoid complications due to misdiagnosis. The correlation of AFST result with real in vivo therapeutic responses can be strain or patient dependent, and this should be considered for a successive treatment.
authors.affiliation: Kashan Shahidbeheshti Hospital, Kashan University of Medical Sciences, Kashan, Iran.
authors.forename: Mahzad
authors.initials: M
authors.lastname: Erami
authors.forename: Hasan
authors.initials: H
authors.lastname: Afzali
authors.forename: Mansoureh Momen
authors.initials: MM
authors.lastname: Heravi
authors.forename: Ali
authors.initials: A
authors.lastname: Rezaei-Matehkolaei
authors.forename: Mohammad Javad
authors.initials: MJ
authors.lastname: Najafzadeh
authors.forename: Maryam
authors.initials: M
authors.lastname: Moazeni
authors.forename: Somayeh
authors.initials: S
authors.lastname: Dolatabadi
authors.forename: Leila
authors.initials: L
authors.lastname: Hosseinpour
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D001168:Arthritis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology* / Q000473:pathology; D041221:Candida glabrata / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology*; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology* / Q000473:pathology; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D008297:Male; D012008:Recurrence
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole
references.citation: Clin Infect Dis. 2004 Aug 15;39(4):598-9; author reply 599
references.pmid: 15356831
references.citation: Acta Orthop Belg. 2002 Oct;68(4):388-91
references.pmid: 12415942
references.citation: Scand J Infect Dis. 2002;34(5):394-6
references.pmid: 12069030
references.citation: Antimicrob Agents Chemother. 1998 Jan;42(1):129-34
references.pmid: 9449272
references.citation: J Arthroplasty. 2004 Oct;19(7):927-30
references.pmid: 15483812
references.citation: Am J Orthop (Belle Mead NJ). 2012 Nov;41(11):500-5
references.pmid: 23431513
references.citation: J Bone Joint Surg Am. 2009 Nov;91 Suppl 6:142-9
references.pmid: 19884422
references.citation: J Infect. 2001 Jan;42(1):74-6
references.pmid: 11243760
references.citation: J Clin Microbiol. 2005 Aug;43(8):4107-11
references.pmid: 16081957